Vergleich der Mengen der leichten Kette des Neurofilaments (NfL) und des sauren Gliafaserproteins (GFAP) im Blut von Patienten mit asymptomatischen Stenosen der Aa. carotides internae für die Evaluation von NfL und GFAP als Biomarker / Cleopatra Papasimos ; Gutachter: Michael Gliem ; Betreuer: Robin Jansen

Related documents

• Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms / Simon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, Eva Krieghoff-Henning, Christoph E. Heilig, Christoph Heining, Andreas Mock, Maria-Veronica Teleanu, Barbara Hutter, Laura Gieldon, Barbara Klink, Katja Beck, Daniela Richter, Annika Baude-Müller, Eva Reisinger, Nils Hammer, Leila Kamkar, Katrin Pfütze, Christina Geörg, Mario Lamping, Damian T. Rieke, Sebastian Uhrig, Henning Jann, Ulrich-Frank Pape, Michael Allgäuer, Albrecht Stenzinger, Eva C. Winkler, Bertram Wiedenmann, Dirk Jäger, Benedikt Brors, Daniel Hübschmann, Evelin Schröck, Ulrich Keilholz, Marianne Pavel, Peter Horak, Hanno Glimm, Stefan Fröhling#1078625
• Transcriptome Sequencing Analysis of Whole Blood From Patients With Trigeminal Neuralgia#833188
• Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO‐10‐27#1079412
• The Migraine and Pain Study GeneBank at Scripps Clinic Registry (MAPS)#1114740
• PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)#1010310